November 12, 2005 (Atlanta, GA)—National Multiple Sclerosis Society recognized Serono / Pfizer's commitment in the fight against MS by inducting them into the Society's Corporate Star Program. Serono / Pfizer is an outstanding contributor for Society programs and a long-time pharmaceutical corporate friend.

Serono/Pfizer's Chris Blanc, center, accepts the Corporate Star award

Serono / Pfizer Executive Business Director, US Neurology, Chris Blanc, accepted the award on behalf of the company at the National MS Society's National Conference in Atlanta, GA. National MS Society former Chairman of the Board, Ed Kangas, and current Chairman of the Board, Weyman Johnson, both presented the award.

The National MS Society Corporate Star program recognizes corporations that encourage volunteerism, lend their good names to fund-raising events, contribute in-kind and cash sponsorship, support the establishment of corporate teams, provide expertise and leadership for society chapters, advocate for increased accessibility for people with multiple sclerosis or other disabilities and fund programs and research for people with MS through foundation grants or corporate gifts.

"The pharmaceutical commitment to people living with MS is both passionate and powerful," said Joyce Nelson, President and CEO of the National MS Society. "Now is the time to eradicate MS, and together we can make this happen."

To learn more about Serono / Pfizer, visit the company web site at www.serono.com.